Targeting the RAF/MEK/ERK, PI3K/AKT and P53 pathways in hematopoietic drug resistance
dc.contributor.author | McCubrey, James A. | en_US |
dc.contributor.author | Steelman, Linda S. | en_US |
dc.contributor.author | Franklin, Richard A. | en_US |
dc.contributor.author | Abrams, Stephen L. | en_US |
dc.contributor.author | Chappell, William H. | en_US |
dc.contributor.author | Wong, Ellis W.T. | en_US |
dc.contributor.author | Lehmann, Brian D. | en_US |
dc.contributor.author | Terrian, David M. | en_US |
dc.contributor.author | Basecke, Jorg | en_US |
dc.contributor.author | Stivala, Franca | en_US |
dc.contributor.author | Libra, Massimo | en_US |
dc.contributor.author | Evangelisti, Camilla | en_US |
dc.contributor.author | Martelli, Alberto M. | en_US |
dc.date.accessioned | 2011-01-21T21:01:56Z | en_US |
dc.date.accessioned | 2011-05-17T01:40:01Z | |
dc.date.available | 2011-01-21T21:01:56Z | en_US |
dc.date.available | 2011-05-17T01:40:01Z | |
dc.date.issued | 2007 | en_US |
dc.identifier.citation | Advances in Enzyme Regulation; 47:1 p. 64-103 | en_US |
dc.identifier.pmid | PMC2696319 | en_US |
dc.identifier.uri | http://hdl.handle.net/10342/3081 | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | East Carolina University | en_US |
dc.relation.uri | http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T3T-4NBR8HF-1&_user=634873&_coverDate=12%2F31%2F2007&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000033758&_version=1&_urlVersion=0&_userid=634873&md5=819562c1e4c3462b24f2705832803fa4&searchtype=a | en_US |
dc.subject | Hematopoietic drug resistance | en_US |
dc.subject | Acute myeloid leukemia | en_US |
dc.subject | RAF/MEK/ERK pathway | en_US |
dc.subject | PI3K/AKT pathway | en_US |
dc.subject | p53 pathway | en_US |
dc.title | Targeting the RAF/MEK/ERK, PI3K/AKT and P53 pathways in hematopoietic drug resistance | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1